The synthesis of a series of new n-propyl and n-butyl chain containing 1-arylpiperazine derivatives of quinazolidin-4(3H)-one (7) 2-phenyl-2,3-dihydrophthalazine-1,4-dione (8) and 1-phenyl-1,2-dihydropyridazine-3,6-dione (9) as potential serotonin receptor ligands is described.
Introduction
Early studies by Hibert et al. have shown that there are two basic pharmacophore groups common to all five classes of 5-HT 1A receptor ligands: a basic nitrogen atom and an aromatic ring with its centre positioned at a distance of 5.2-5.7 Å [1] . Since then several attempts have been made to extend that model, but the large diversity of ligand structures made definition of general interaction modes impossible. In consequence, a search for other pharmacophore groups was limited to single classes or subgroups of ligands [2] [3] [4] [5] . In the case of 1-arylpiperazine derivatives -the biggest and thoroughly investigated class of 5-HT 1A receptor ligands [6] -an amide moiety [7] or an amide oxygen atom [8] was suggested as a third interaction point; however, the authors developed those models on the basis of a relatively small group of compounds. Extensive CoMFA investigation of a large set of 1-arylpiperazine derivatives has revealed that in this third interaction region different forces, e.g. steric, electrostatic or lipophilic, may influence the ligand-receptor complex formation [9] . Since the role of the amide fragment in ligand-receptor interactions is still unclear systematic structure affinity relationship studies are necessary.
Recently we described the synthesis and pharmacological results concerning new arylpiperazine derivatives with systematic modifications in the amide part, i.e. 1-arylpiperazine derivatives of benzoxazinone 1-4, benzoxazolinone 5 and benzoxazolindione 6 [10] .
The majority of these compounds have a distinct affinity for 5-HT 1A and/or 5-HT 2A receptor binding sites. Radioligand binding studies have shown that compounds 1b, 2a-b, 2d-e, 4b and 6e-f have a good (K i = 1.25 -40 nM) and compounds 1a, 3a-b and 5a-b a moderate (K i = 72-110 nM) affinity for 5-HT 1A receptors. The 5-HT 2A affinity of the obtained compounds was within a range of K i = 18 -495 nM. On the other hand Buspirone -{4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl}-8-azaspiro [4.5] decane-7,9-dione -approved as the anxiolytic drug, and its two analogues Ipsapirone and Gepirone bind with high affinity and selectivity to 5-HT 1A serotonin receptor sites. Therefore, in order to throw more light on ligand -5-HT 1A receptor interactions we designed new model 1-phenylpiperazine and 1-(2-pyrimidinyl)piperazine derivatives with systematic structural changes within the terminal amide part. 
Results and Discussion
We present in this paper the synthesis of new N-
in which the length of a spacer, arylpiperazine and terminal amide fragment were systematically modified. Preliminary investigation results on affinities of obtained compounds for 5HT 1A and 5HT 2A receptor sites are also presented.
Scheme 1.
Starting materials quinazolidin-4(3H)-one (7), 2-phenyl-2,3-dihydrophtalazine-1,4-dione (8) and 1-phenyl-1,2-dihydropyridazine-3,6-dione (9) were obtained according to procedures described in the literature. Quinazolidin-4(3H)-one (7) was obtained from antranilic acid [11], 2-phenyl-2,3-dihydrophtalazine-1,4-dione (8) from ftalic anhydride [12] , while 1-phenyl-1,2-dihydropyridazine-3,6-dione (9) from maleic anhydride [13] . formation of the N-substituted derivatives 16-19 and 20-23 respectively, in agreement with both our own and literature reports on the structural determination of substituted lactams [14] [15] [16] [17] [18] [19] [20] [21] . Reactions were carried out in acetonitrile in the presence of anhydrous K 2 CO 3 . Reaction yields and the properties of the obtained compounds are presented in the Experimental section of the paper. The mass spectra of the compounds 7a-d, 8a-d, 9a-d (Scheme 4) generally show the presence of molecular ions of weak intensity.
Scheme 4.
The base peaks of the investigated compounds mainly correspond to [CH 2 =NR 2 ] + ion formation:
m/z=175; m/z=177. This is in agreement with the general patterns observed for alkylamine fragmentation [22] [23] . In case of derivatives 7a-b, 8a-b, 9a-b, with a three member spacer chain, we find that fragmentation leads to fragments with m/z=187, m/z=279 and m/z=229 respectively, which are consistent with the behaviour of alkyl substituted lactams in mass spectroscopy [23] ( CH 
Experimental

General
Elemental analyses were performed on a Perkin-Elmer 2400 analyser. EI mass spectra were carried out with a Varian MAT 112 spectrometer at 70 eV. The 1 H-NMR spectra were recorded in deuterochloroform with a Tesla 487C (80 MHz) spectrometer and using tetramethylsilane (TMS) as an internal standard; the chemical shifts are reported in ppm (δ); coupling constants were taken from the expanded spectrum. IR spectra were recorded on a Bio-Rad FTS-175C spectrophotometer in KBr pellets. Melting points were determined in a Boetius apparatus and are uncorrected. For biological experiments, free bases 7a-d, 8a-d, 9a-d were converted into their hydrochloride salts and their molecular formulas and molecular weights were established on the basis of an elemental analysis.
General procedure for preparation of derivatives 12, 13, 16, 17, 20 and 21
A mixture of the lactam 7 or 8 or 9 (0.1 mole), the appropriate 1-bromo-3-chloropropane (10) (0.12 mole) or 1,4-dibromobutane (11) (0.12 mole), powdered K 2 CO 3 (20.7 g, 0.15 mole) and a catalytic amount of KI in acetonitrile (200 mL) was stirred and refluxed 24 h (Scheme 2). The cold reaction mixture was filtered and the filter cake washed with cold acetonitrile (20 mL). The combined filtrates were evaporated to dryness and the residue was purified by recrystallisation. Reaction yields and physical properties of the obtained compounds 12, 13, 16, 17, 20 and 21 are given in 
General procedure for the preparation of hydrochlorides
Free bases 7a-d, 8a-d and 9a-d were converted into their hydrochlorides by dissolving the corresponding base in acetone (10mL/g) and treating with ethanol saturated with HCl. The precipitate was filtered off and washed with acetone. Some of the hydrochlorides were additionally purified by recrystallisation.
3-[3-(4-phenyl-1-piperazinyl)propyl]-quinazolidin-4(3H)-one (7a)
Base 7a 
3-{3-[4-(2-pyrimidinyl)-1-piperazinyl]propyl}-quinazolidin-4(3H)-one (7b)
Base
3-[4-(4-phenyl-1-piperazinyl)butyl]-quinazolidin-4(3H)-one
3-{4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl}-quinazolidin-4(3H)-one
3-{3-[4-(2-pyrimidinyl)-1-piperazinyl]propyl}-2-phenyl-2,3-dihydrophthalazine-1,4-dione
